Neurodegenerative Diseases
153
36
44
61
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
11 trials with published results (7%)
Research Maturity
61 completed trials (40% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.3%
5 terminated out of 153 trials
92.4%
+5.9% vs benchmark
5%
7 trials in Phase 3/4
18%
11 of 61 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 61 completed trials
Clinical Trials (153)
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
AMX0035 and Progressive Supranuclear Palsy
Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
Retinal Hyperspectral Imaging in Neurodegenerative Diseases
A Phase 3 Study of NTLA-2001 in ATTRv-PN
Decision-making, Ethical Consent, and Interactive Dialogue in Ongoing Neurocognitive Decline - DECISION
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
Novel Technologies to Measure Vision-related Quality of Life
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
Study on the Application of ¹⁸F-FCOB04, a MAO-B Targeted PET Imaging Agent, in Neurodegenerative Diseases
NAD+ Oral Supplement Pilot Intervention in Adult Females
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Kamlanoflast In Amyotrophic Lateral Sclerosis
Continuation Study for Latozinemab
Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
Normal Chinese Lifespan Brain Charts Initiative (NCLBCI)
Validation of the VIRADIA App for Neurological and Cognitive Diagnostics in Virtual Reality
Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS Neuropathies